Patents by Inventor Jui-Pao HSU

Jui-Pao HSU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10639292
    Abstract: Disclosed herein are methods for treating conditions and/or disorders related to hyperglycemia. Such conditions and/or disorders related to hyperglycemia include, but are not limited to, type I, II diabetes mellitus, gestational diabetes, other forms diabetes, and disorders related thereto. In particular, the present invention relates to methods of using (R)-(+)-verapamil or a pharmaceutically acceptable salt thereof and an ?-glycosidase inhibitor in the treatment of conditions and/or disorders related to hyperglycemia.
    Type: Grant
    Filed: November 3, 2018
    Date of Patent: May 5, 2020
    Assignee: CENTER LABORATORIES, INC.
    Inventors: Jui-Pao Hsu, Guang-Tzuu Shane, Meng-Ju Lee, Yi-Ping Liao, Yu-Yin Yeh, Shu-Hsien Chang
  • Publication number: 20190321326
    Abstract: Disclosed herein are methods for treating conditions and/or disorders related to hyperglycemia. Such conditions and/or disorders related to hyperglycemia include, but are not limited to, type I, II diabetes mellitus, gestational diabetes, other forms diabetes, and disorders related thereto. In particular, the present invention relates to methods of using (R)-(+)-verapamil or a pharmaceutically acceptable salt thereof and an ?-glycosidase inhibitor in the treatment of conditions and/or disorders related to hyperglycemia.
    Type: Application
    Filed: November 3, 2018
    Publication date: October 24, 2019
    Applicant: Center Laboratories, Inc.
    Inventors: Jui-Pao HSU, Guang-Tzuu SHANE, Meng-Ju LEE, Yi-Ping LIAO, Yu-Yin YEH, Shu-Hsien CHANG
  • Publication number: 20190321327
    Abstract: Disclosed herein are methods for treating conditions and/or disorders related to hyperglycemia. In particular, the present invention relates to methods of using (R)-(+)-verapamil or a pharmaceutically acceptable salt thereof and insulin or an insulin analogue in the treatment of mellitus and/or disorders related to diabetes mellitus.
    Type: Application
    Filed: March 25, 2019
    Publication date: October 24, 2019
    Applicant: Center Laboratories, Inc.
    Inventors: Jui-Pao HSU, Guang-Tzuu SHANE, Meng-Ju LEE, Yi-Ping LIAO, Yu-Yin YEH, Shu-Hsien CHANG
  • Patent number: 10278943
    Abstract: Disclosed herein are methods for treating conditions and/or disorders related to hyperglycemia. Such conditions and/or disorders related to hyperglycemia include, but are not limited to, type I, II diabetes mellitus, gestational diabetes, other forms diabetes, and disorders related thereto. In particular, the present invention relates to methods of using (R)-(+)-verapamil or a pharmaceutically acceptable salt thereof in the treatment of conditions and/or disorders related to hyperglycemia.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: May 7, 2019
    Assignee: Center Laboratories, Inc.
    Inventors: Jui-Pao Hsu, Guang-Tzuu Shane, Meng-Ju Lee, Yi-Ping Liao, Yu-Yin Yeh
  • Patent number: 10144704
    Abstract: Novel crystal forms of (R)-(+)-verapamil hydrochloride are disclosed.
    Type: Grant
    Filed: March 11, 2018
    Date of Patent: December 4, 2018
    Assignee: Center Laboratories, Inc.
    Inventors: Jui-Pao Hsu, Guang-Tzuu Shane, Yu-Yin Yeh, Meng-Ju Lee
  • Publication number: 20180235921
    Abstract: Disclosed herein are methods for treating conditions and/or disorders related to hyperglycemia. Such conditions and/or disorders related to hyperglycemia include, but are not limited to, type I, II diabetes mellitus, gestational diabetes, other forms diabetes, and disorders related thereto. In particular, the present invention relates to methods of using (R)-(+)-verapamil or a pharmaceutically acceptable salt thereof in the treatment of conditions and/or disorders related to hyperglycemia.
    Type: Application
    Filed: April 20, 2018
    Publication date: August 23, 2018
    Applicant: Center Laboratories, Inc.
    Inventors: Jui-Pao HSU, Guang-Tzuu SHANE, Meng-Ju LEE, Yi-Ping LIAO, Yu-Yin YEH
  • Publication number: 20180194719
    Abstract: Novel crystal forms of (R)-(+)-verapamil hydrochloride are disclosed.
    Type: Application
    Filed: March 11, 2018
    Publication date: July 12, 2018
    Applicant: Center Laboratories, Inc.
    Inventors: Jui-Pao HSU, Guang-Tzuu SHANE, Yu-Yin YEH, Meng-Ju LEE
  • Patent number: 9980935
    Abstract: Disclosed herein are methods for treating conditions and/or disorders related to hyperglycemia. Such conditions and/or disorders related to hyperglycemia include, but are not limited to, type I, II diabetes mellitus, gestational diabetes, other forms diabetes, and disorders related thereto. In particular, the present invention relates to methods of using (R)-(+)-verapamil or a pharmaceutically acceptable salt thereof in the treatment of conditions and/or disorders related to hyperglycemia.
    Type: Grant
    Filed: May 17, 2017
    Date of Patent: May 29, 2018
    Inventors: Jui-Pao Hsu, Guang-Tzuu Shane, Meng-Ju Lee, Yi-Ping Liao, Yu-Yin Yeh
  • Patent number: 9950995
    Abstract: Novel crystal forms of (R)-(?)-verapamil hydrochloride are disclosed.
    Type: Grant
    Filed: July 13, 2015
    Date of Patent: April 24, 2018
    Inventors: Jui-Pao Hsu, Guang-Tzuu Shane, Yu-Yin Yeh, Meng-Ju Lee
  • Publication number: 20170333382
    Abstract: Disclosed herein are methods for treating conditions and/or disorders related to hyperglycemia. Such conditions and/or disorders related to hyperglycemia include, but are not limited to, type I, II diabetes mellitus, gestational diabetes, other forms diabetes, and disorders related thereto. In particular, the present invention relates to methods of using (R)-(+)-verapamil or a pharmaceutically acceptable salt thereof in the treatment of conditions and/or disorders related to hyperglycemia.
    Type: Application
    Filed: May 17, 2017
    Publication date: November 23, 2017
    Applicant: Center Laboratories, Inc.
    Inventors: Jui-Pao HSU, Guang-Tzuu SHANE, Meng-Ju LEE, Yi-Ping LIAO, Yu-Yin YEH
  • Publication number: 20170305841
    Abstract: Novel crystal forms of (R)-(?)-verapamil hydrochloride are disclosed.
    Type: Application
    Filed: July 13, 2015
    Publication date: October 26, 2017
    Applicant: Center Laboratories, Inc.
    Inventors: Jui-Pao HSU, Guang-Tzuu SHANE, Yu-Yin YEH, Meng-Ju LEE